Post‐transcriptional regulation in cancer
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Summry— Deregulation of gene expression is a hallmark of the cancer cell. Acquiring a new profile of expressed proteins may enable the cell to re‐enter the cell cycle, or give them a growth or motility advantage over “normal cells”. An efficient and rapid way to alter gene expression is via regulation of mRNAs already transcribed. Modifications of mRNA stability and/or translational efficiency are increasingly reported in cancer. mRNA stability and translation are controlled through a complex network of RNA/protein interactions involving recognition of specific target mRNAs by RNA‐BPs. We review how alterations in regulatory sequences, RNA‐BPs, or in upstream signalling pathways affect the stability and/or translational efficiency of mRNAs encoding proto‐oncogenes, cytokines, cell cycle regulators and other regulatory proteins to promote tumorigenesis and cancer progression. A more thorough understanding of post‐transcriptional mechanisms such as these will enable the design and development of specific therapies based on modulating the translation or stability of specific mRNAs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532 · cited 2×
“While TNF-a was originally named for its ability to induce necrosis of tumors (Carswell et al., 1975), it harbours numerous tumor-promoting activities such as induction of angiogenic factors, activation of matrix metalloproteases (Leber and Balkwill, 1998; Rosen et al.”
BackgroundOncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951 · cited 2×
“The proto-oncogene mdm2 encodes an E3 ubiquitin ligase that activates degradation of the transcription factor p53 (Fang et al., 2000; Honda et al., 1997).”
BackgroundAU-rich elements: characterization and importance in mRNA degradation
Chen, C.-Y. A., & Shyu, A.-B. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89102-1 · Cited by 1,948 · cited 1×
“…in normal cells (Dani et al., 1984), with its translation and stability controlled by at least three different mechanisms: AREs in its 3′UTR (Herrick and Ross, 1994, and reviewed in Chen and Shyu, 1995), a coding region determinant (Wisdom and Lee, 1991), and a 5’UTR internal ribosomal entry site.”
BackgroundThe p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044
Molecular basis of the VHL hereditary cancer syndrome
Kaelin, W. G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc885 · Cited by 865 · cited 1×
“In particular, patients may develop renal cell carcinomas (for a review see Kaelin, 2002).”
BackgroundLau, L. F., & Nathans, D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1182 · Cited by 856
Post-transcriptional Regulation of Vascular Endothelial Growth Factor by Hypoxia
Levy, A. P., Levy, N. S., & Goldberg, M. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2746 · Cited by 629
Imataka, H., Gradi, A., & Sonenberg, N. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7480 · Cited by 572 · cited 1×
“PABP1 is also known to interact directly with the translation initiation factor eIF4G (Imataka et al., 1998), bridging the 5’ and 3’ UTRs (Fig.”
BackgroundSzabo, A., Dalmau, J., Manley, G., Rosenfeld, M., Wong, E., Henson, J., Posner, J. B., & Furneaux, H. M. (1991) · Cell · doi:10.1016/0092-8674(91)90184-z · Cited by 553
Comparative genomics and evolution of proteins involved in RNA metabolism
Anantharaman, V. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.7.1427 · Cited by 541
Identification of a target RNA motif for RNA-binding protein HuR
de Silanes, I. L., Zhan, M., Lal, A., Yang, X., & Gorospe, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306453101 · Cited by 502 · cited 1×
“A recent work performed in Gorospe lab used immunoprecipitation of the HuR containing RNA/protein complex to identify globally the HuR mRNA target (Lopez de Silanes et al., 2004).”
MethodMathas, S., Hinz, M., Anagnostopoulos, I., Krappmann, D., Lietz, A., Jundt, F., Bommert, K., Mechta‐Grigoriou, F., Stein, H., Dörken, B., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf389 · Cited by 375
ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5′UTR
Kullmann, M., Göpfert, U., Siewe, B., & Hengst, L. (2002) · Genes & Development · doi:10.1101/gad.248902 · Cited by 327 · cited 1×
“This U-rich element is part of a 5′UTR IRES through which HuR negatively regulates p27 translation (Kullmann et al., 2002).”
BackgroundA Mechanism for Translationally Coupled mRNA Turnover
Grosset, C., Chen, C.-Y. A., Xu, N., Sonenberg, N., Jacquemin-Sablon, H., & Shyu, A.-B. (2000) · Cell · doi:10.1016/s0092-8674(00)00102-1 · Cited by 295 · cited 2×
“This CRD is also sufficient for the specific binding of a complex of proteins (Chen et al., 1992; Grosset et al., 2000).”
BackgroundDuret, L., Dorkeld, F., & Gautier, C. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.10.2315 · Cited by 160 · cited 1×
“Across the animal kingdom, numerous conserved sequence elements are located in the untranslated regions of mRNAs, suggesting an important role for these elements (Duret et al., 1993).”
Background
Cited by
RNA regulons: coordination of post-transcriptional events
Keene, J. D. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2111 · Cited by 1,321
“Thus, dysregulation of an RNA operon or failure of an mRNA to be properly expressed could be relevant to complex human disease”
BackgroundAU-rich elements and associated factors: are there unifying principles?
Barreau, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki1012 · Cited by 907
Control of cytokine mRNA expression by RNA-binding proteins and microRNAs
Palanisamy, V., Jakymiw, A., Van Tubergen, E. A., D’Silva, N. J., & Kirkwood, K. L. (2012) · Journal of Dental Research · doi:10.1177/0022034512437372 · Cited by 117
“The aberrant expression of cytokines has been correlated with inflammatory diseases, autoimmune disorders, and cancer (Audic and Hartley, 2004).”
BackgroundRegulatory RNA-binding proteins in senescence
Wang, W. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.02.006 · Cited by 27
Metadata
- Authors
- Audic, Y., & Hartley, R. S.
- Venue
- Biology of the Cell
- Publisher
- Wiley
- Published
- 2004-09
- Volume
- 96
- Issue
- 7
- Pages
- 479-498
- ISSN
- 0248-4900 (ISSN-L)
- 1768-322X
- OpenAlex
- W2046456420
- Cited by
- 234
- References
- 17
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.